Günter Eisele

1.6k total citations
27 papers, 1.2k citations indexed

About

Günter Eisele is a scholar working on Genetics, Molecular Biology and Immunology. According to data from OpenAlex, Günter Eisele has authored 27 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 8 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Günter Eisele's work include Glioma Diagnosis and Treatment (10 papers), Immune Cell Function and Interaction (6 papers) and Immunotherapy and Immune Responses (5 papers). Günter Eisele is often cited by papers focused on Glioma Diagnosis and Treatment (10 papers), Immune Cell Function and Interaction (6 papers) and Immunotherapy and Immune Responses (5 papers). Günter Eisele collaborates with scholars based in Switzerland, Germany and United States. Günter Eisele's co-authors include Michael Weller, Jörg Wischhusen, Patrick Roth, Wolfgang Wick, Alexander Steinle, Markus Weiler, Manuel A. Friese, Caroline Happold, Fabian Wolpert and Silvia Höfer and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Brain.

In The Last Decade

Günter Eisele

27 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Günter Eisele Switzerland 16 462 450 433 273 253 27 1.2k
Candice C. Poon Canada 9 459 1.0× 344 0.8× 394 0.9× 177 0.6× 127 0.5× 14 1.2k
Christine Dictus Germany 9 240 0.5× 454 1.0× 668 1.5× 560 2.1× 274 1.1× 9 1.3k
Satoru Osuka Japan 21 166 0.4× 677 1.5× 355 0.8× 390 1.4× 314 1.2× 42 1.3k
Joanne L. Attema Australia 17 477 1.0× 1.1k 2.4× 205 0.5× 284 1.0× 368 1.5× 21 1.8k
Nicole Parker Australia 10 165 0.4× 388 0.9× 391 0.9× 239 0.9× 276 1.1× 16 1.1k
Rimas V. Lukas United States 17 208 0.5× 229 0.5× 318 0.7× 399 1.5× 133 0.5× 66 993
Cédric Dos Santos United States 16 396 0.9× 762 1.7× 571 1.3× 169 0.6× 76 0.3× 36 1.5k
Tanaya Shree United States 9 591 1.3× 456 1.0× 657 1.5× 53 0.2× 337 1.3× 27 1.4k
Abhik Ray Chaudhury United States 17 355 0.8× 419 0.9× 401 0.9× 84 0.3× 70 0.3× 26 1.0k
Scott H. Olejniczak United States 16 285 0.6× 517 1.1× 439 1.0× 203 0.7× 190 0.8× 41 1.2k

Countries citing papers authored by Günter Eisele

Since Specialization
Citations

This map shows the geographic impact of Günter Eisele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Günter Eisele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Günter Eisele more than expected).

Fields of papers citing papers by Günter Eisele

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Günter Eisele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Günter Eisele. The network helps show where Günter Eisele may publish in the future.

Co-authorship network of co-authors of Günter Eisele

This figure shows the co-authorship network connecting the top 25 collaborators of Günter Eisele. A scholar is included among the top collaborators of Günter Eisele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Günter Eisele. Günter Eisele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hertler, Caroline, Günter Eisele, Dorothee Gramatzki, et al.. (2020). End-of-life care for glioma patients; the caregivers’ perspective. Journal of Neuro-Oncology. 147(3). 663–669. 15 indexed citations
2.
Eisele, Günter, Ulrich Roelcke, Katrin Conen, et al.. (2018). Complementary and alternative medicine use by glioma patients in Switzerland. Neuro-Oncology Practice. 6(3). 237–244. 11 indexed citations
3.
Neidert, Marian C., Daniel J. Kowalewski, Manuela Silginer, et al.. (2018). The natural HLA ligandome of glioblastoma stem-like cells: antigen discovery for T cell-based immunotherapy. Acta Neuropathologica. 135(6). 923–938. 29 indexed citations
4.
Neidert, Marian C., Isabel C. Hostettler, Jan-Karl Burkhardt, et al.. (2016). The influence of intraoperative resection control modalities on survival following gross total resection of glioblastoma. Neurosurgical Review. 39(3). 401–409. 22 indexed citations
5.
Wolpert, Fabian, Caroline Happold, Guido Reifenberger, et al.. (2015). Interferon-β Modulates the Innate Immune Response against Glioblastoma Initiating Cells. PLoS ONE. 10(10). e0139603–e0139603. 10 indexed citations
6.
Weller, Michael, et al.. (2014). Carboplatin and Etoposide in Heavily Pretreated Patients with Progressive High-Grade Glioma. Chemotherapy. 60(5-6). 375–378. 9 indexed citations
7.
Eisele, Günter, Antje Wick, Paul M. Clément, et al.. (2014). Cilengitide treatment of newly diagnosed glioblastoma patients does not alter patterns of progression. Journal of Neuro-Oncology. 117(1). 141–145. 48 indexed citations
8.
Wolpert, Fabian, Isabel Tritschler, Alexander Steinle, Michael Weller, & Günter Eisele. (2013). A disintegrin and metalloproteinases 10 and 17 modulate the immunogenicity of glioblastoma-initiating cells. Neuro-Oncology. 16(3). 382–391. 49 indexed citations
9.
Roth, Patrick, Roger Stupp, Günter Eisele, & Michael Weller. (2013). Treatment of Primary CNS Lymphoma. Current Treatment Options in Neurology. 16(1). 277–277. 12 indexed citations
10.
Eisele, Günter, et al.. (2013). APO010, a synthetic hexameric CD95 ligand, induces death of human glioblastoma stem-like cells. PubMed. 33(9). 3563–71. 11 indexed citations
11.
Wolpert, Fabian, Patrick Roth, Katrin Lamszus, et al.. (2012). HLA-E contributes to an immune-inhibitory phenotype of glioblastoma stem-like cells. Journal of Neuroimmunology. 250(1-2). 27–34. 36 indexed citations
12.
Roth, Patrick, Günter Eisele, & Michael Weller. (2012). Immunology of brain tumors. Handbook of clinical neurology. 104. 45–51. 10 indexed citations
13.
Schreglmann, Sebastian R., Andreas R. Gantenbein, Günter Eisele, & Christian R. Baumann. (2011). Transdermal rotigotine causes impulse control disorders in patients with restless legs syndrome. Parkinsonism & Related Disorders. 18(2). 207–209. 37 indexed citations
14.
Roth, Patrick, Jörg Wischhusen, Caroline Happold, et al.. (2011). A specific miRNA signature in the peripheral blood of glioblastoma patients. Journal of Neurochemistry. 118(3). 449–457. 172 indexed citations
15.
Eisele, Günter & Michael Weller. (2011). Targeting apoptosis pathways in glioblastoma. Cancer Letters. 332(2). 335–345. 69 indexed citations
16.
Eisele, Günter, Peter Roth, Kathy Hasenbach, et al.. (2010). APO010, a synthetic hexameric CD95 ligand, induces human glioma cell death in vitro and in vivo. Neuro-Oncology. 13(2). 155–164. 38 indexed citations
17.
Roth, Patrick, Maria Kissel, Günter Eisele, et al.. (2009). SC68896, a Novel Small Molecule Proteasome Inhibitor, Exerts Antiglioma Activity In vitro and In vivo. Clinical Cancer Research. 15(21). 6609–6618. 15 indexed citations
18.
Happold, Caroline, Patrick Roth, Wolfgang Wick, et al.. (2008). ACNU-based chemotherapy for recurrent glioma in the temozolomide era. Journal of Neuro-Oncology. 92(1). 45–48. 32 indexed citations
19.
Roth, Patrick, et al.. (2008). A series of patients with subpial hemorrhage: Clinical manifestation, neuroradiological presentation and therapeutic implications. Journal of Neurology. 255(7). 1018–1022. 16 indexed citations
20.
Eisele, Günter. (2006). TGF-  and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells. Brain. 129(9). 2416–2425. 181 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Candice C. Poon Breakdown of academic impact, for papers by Christine Dictus Breakdown of academic impact, for papers by Satoru Osuka Breakdown of academic impact, for papers by Joanne L. Attema Breakdown of academic impact, for papers by Nicole Parker Breakdown of academic impact, for papers by Rimas V. Lukas Breakdown of academic impact, for papers by Cédric Dos Santos Breakdown of academic impact, for papers by Tanaya Shree Breakdown of academic impact, for papers by Abhik Ray Chaudhury Breakdown of academic impact, for papers by Scott H. Olejniczak
Rankless by CCL
2026